Korsana Biosciences, Inc. (KRSA) Stock Ticker
Market factors today
Unlock the full KRSA picture
About Korsana Biosciences, Inc.
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
KRSA stock facts
| Ticker symbol | KRSA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $145.1M |
| CEO | Jonathan Violin |
| Employees | 1 |
| Headquarters | Waltham, MA, US |
| IPO date | 2026-09-09 |
| Website | korsana.com |
What you can see for KRSA on Tickr
Live KRSA price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the KRSA report.
Rankings
FAQ
What is the ticker symbol for Korsana Biosciences, Inc.?
The ticker symbol for Korsana Biosciences, Inc. is KRSA, listed on the NASDAQ.
What is KRSA?
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is…